Avenue Therapeutics Inc. (NASDAQ: ATXI)
$3.57
+0.0800 ( +2.29% ) 8.2K
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.
Market Data
Open
$3.57
Previous close
$3.49
Volume
8.2K
Market cap
$3.29M
Day range
$3.41 - $3.72
52 week range
$3.21 - $91.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Jun 26, 2024 |
8-k | 8K-related | 14 | May 23, 2024 |
8-k | 8K-related | 16 | May 15, 2024 |
10-q | Quarterly Reports | 56 | May 15, 2024 |
8-k | 8K-related | 16 | May 13, 2024 |
def | Proxies and info statements | 5 | May 06, 2024 |
8-k | 8K-related | 20 | May 01, 2024 |
8-k | 8K-related | 17 | Apr 26, 2024 |
4 | Insider transactions | 1 | Apr 17, 2024 |
8-k | 8K-related | 14 | Mar 29, 2024 |